Download PDF
CC BY-NC-ND 4.0 · European Journal of General Dentistry 2020; 9(01): 1-6
DOI: 10.4103/ejgd.ejgd_100_19
Review Article

Oral health and nicotine replacement therapy product

Jane Manakil
School of Dentistry and Oral Health, Griffith University, Gold Coast, Australia
,
Andrew Miliankos
School of Dentistry and Oral Health, Griffith University, Gold Coast, Australia
,
Megan Gray
School of Dentistry and Oral Health, Griffith University, Gold Coast, Australia
,
Anut Itthagarun
School of Dentistry and Oral Health, Griffith University, Gold Coast, Australia
,
Roy George
School of Dentistry and Oral Health, Griffith University, Gold Coast, Australia
› Author Affiliations
› Further Information
Also available at
   Permissions and Reprints

Abstract

Nicotine replacement therapy (NRT) products are used extensively for assisting users in achieving cessation goals through the substitution of pure nicotine with tobacco-less products. Awareness of the adverse oral effects of nicotine replacement products is important for health practitioners. This review highlights the potential effects of NRT products on the oral tissues and management of these adverse effects. Cochrane, PubMed, and MEDLINE electronic databases were utilized in search of the relevant literature related to NRT. The review highlights various adverse effects on oral health status from NRT products, with the underlying mechanisms for these effects remaining inconclusive. There is a need for more education of health professionals in oral health promotion and maintenance in these cases. NRT products have many potential adverse effects on oral health, and it is the responsibility of dental professionals to consider these in the management of patients to optimize a beneficial clinical outcome.

Keywords

Mouth neoplasms - nicotine replacement products - oral health - periodontal diseases - smoking - tobacco

Financial support and sponsorship

Nil.




Publication History

Article published online:
01 November 2021

© 2020. European Journal of General Dentistry. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Collins D, Lapsley H. The social costs of smoking in Australia. N S W Public Health Bull 2004;15:92-4.
  • 2 Moore D, Aveyard P, Connock M, Wang D, Fry-Smith A, Barton P. Effectiveness and safety of nicotine replacement therapy assisted reduction to stop smoking: Systematic review and meta-analysis. BMJ 2009;338:b1024.
  • 3 GBD 2015 Tobacco Collaborators. Smoking prevalence and attributable disease burden in 195 countries and territories, 1990-2015: A systematic analysis from the Global Burden of Disease Study 2015. Lancet 2017;389:1885-906.
  • 4 Scollo MM, Winstanley MH. Tobacco in Australia: Facts and Issues. Melbourne: Cancer Council Victoria; 2015. Available from: http://www.tobaccoinaustralia.org.au/chapter-3-health-effects/3-3-smoking- and-cancer. [Last accessed on 2019 Dec 03].
  • 5 Jamerson BD, Nides M, Jorenby DE, Donahue R, Garrett P, Johnston JA, et al. Late-term smoking cessation despite initial failure: An evaluation of bupropion sustained release, nicotine patch, combination therapy, and placebo. Clin Ther 2001;23:744-52.
  • 6 Fernö O. Conversation with ove fernö. Addiction 1994;89:1215-26.
  • 7 Stead LF, Perera R, Bullen C, Mant D, Hartmann-Boyce J, Cahill K, et al. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev 2012;11:CD000146.
  • 8 Silagy C, Mant D, Fowler G, Lodge M. Meta-analysis on efficacy of nicotine replacement therapies in smoking cessation. Lancet 1994;343:139-42.
  • 9 Hjalmarson AI. Effect of nicotine chewing gum in smoking cessation. A randomized, placebo-controlled, double-blind study. JAMA 1984;252:2835-8.
  • 10 Liu Y, Liu BA. Enhanced proliferation, invasion, and epithelial-mesenchymal transition of nicotine-promoted gastric cancer by periostin. World J Gastroenterol 2011;17:2674-80.
  • 11 Hjalmarson A, Nilsson F, Sjöström L, Wiklund O. The nicotine inhaler in smoking cessation. Arch Intern Med 1997;157:1721-8.
  • 12 Shin VY, Cho CH. Nicotine and gastric cancer. Alcohol 2005;35:259-64.
  • 13 Grana R, Benowitz N, Glantz SA. E-cigarettes: A scientific review. Circulation 2014;129:1972-86.
  • 14 Shiffman S, Fant RV, Buchhalter AR, Gitchell JG, Henningfield JE. Nicotine delivery systems. Expert Opin Drug Deliv 2005;2:563-77.
  • 15 Bohadana A, Nilsson F, Rasmussen T, Martinet Y. Nicotine inhaler and nicotine patch as a combination therapy for smoking cessation: A randomized, double-blind, placebo-controlled trial. Arch Intern Med 2000;160:3128-34.
  • 16 Haustein KO, Krause J, Haustein H, Rasmussen T, Cort N. Comparison of the effects of combined nicotine replacement therapy vs. Cigarette smoking in males. Nicotine Tob Res 2003;5:195-203.
  • 17 Mills EJ, Wu P, Lockhart I, Wilson K, Ebbert JO. Adverse events associated with nicotine replacement therapy (NRT) for smoking cessation. A systematic review and meta-analysis of one hundred and twenty studies involving 177,390 individuals. Tob Induc Dis 2010;8:8.
  • 18 Blondal T, Gudmundsson LJ, Olafsdottir I, Gustavsson G, Westin A. Nicotine nasal spray with nicotine patch for smoking cessation: randomised trial with six year follow up. BMJ 1999;318:285-8.
  • 19 Karaconji IB. Facts about nicotine toxicity. Arh Hig Rada Toksikol 2005;56:363-71.
  • 20 Rassool GH. Ch. 9. Nicotine. Addiction for Nurses. Oxford, UK: Wiley-Blackwell Publishing; 2010. p. 90-9. Available from: http://www.wiley.com/wiley-blackwell. [Last accessed on 2019 Dec 02].
  • 21 Roe FJ. Effects of nicotine on biological-systems – Hamburg, frg 28-30 June 1990. Trends Pharmacol Sci 1990;11:346-7.
  • 22 Yildiz D. Nicotine, its metabolism and an overview of its biological effects. Toxicon 2004;43:619-32.
  • 23 Benowitz NL. Pharmacology of nicotine: Addiction and therapeutics. Annu Rev Pharmacol Toxicol 1996;36:597-613.
  • 24 Riebel GD, Boden SD, Whitesides TE, Hutton WC. The effect of nicotine on incorporation of cancellous bone graft in an animal model. Spine (Phila Pa 1976) 1995;20:2198-202.
  • 25 Geng Y, Savage SM, Johnson LJ, Seagrave J, Sopori ML. Effects of nicotine on the immune response. I. Chronic exposure to nicotine impairs antigen receptor-mediated signal transduction in lymphocytes. Toxicol Appl Pharmacol 1995;135:268-78.
  • 26 Geng Y, Savage SM, Razani-Boroujerdi S, Sopori ML. Effects of nicotine on the immune response. II. Chronic nicotine treatment induces T cell anergy. J Immunol 1996;156:2384-90.
  • 27 Kalra R, Singh SP, Pena-Philippides JC, Langley RJ, Razani-Boroujerdi S, Sopori ML. Immunosuppressive and anti-inflammatory effects of nicotine administered by patch in an animal model. Clin Diagn Lab Immunol 2004;11:563-8.
  • 28 Singh SP, Kalra R, Puttfarcken P, Kozak A, Tesfaigzi J, Sopori ML. Acute and chronic nicotine exposures modulate the immune system through different pathways. Toxicol Appl Pharmacol 2000;164:65-72.
  • 29 McAllister-Sistilli CG, Caggiula AR, Knopf S, Rose CA, Miller AL, Donny EC. The effects of nicotine on the immune system. Psychoneuroendocrinology 1998;23:175-87.
  • 30 de Almeida TF, Romana-Souza B, Machado S, Abreu-Villaça Y, Monte-Alto-Costa A. Nicotine affects cutaneous wound healing in stressed mice. Exp Dermatol 2013;22:524-9.
  • 31 Mosely LH, Finseth F, Goody M. Nicotine and its effect on wound healing. Plast Reconstr Surg 1978;61:570-5.
  • 32 Hollinger JO, Schmitt JM, Hwang K, Soleymani P, Buck D. Impact of nicotine on bone healing. J Biomed Mater Res 1999;45:294-301.
  • 33 Nakayama Y, Mezawa M, Araki S, Sasaki Y, Wang S, Han J, et al. Nicotine suppresses bone sialoprotein gene expression. J Periodontal Res 2009;44:657-63.
  • 34 Saito Y, Sato S, Oginuma T, Saito Y, Arai Y, Ito K. Effects of nicotine on guided bone augmentation in rat calvarium. Clin Oral Implants Res 2013;24:531-5.
  • 35 Raulin LA, McPherson JC 3rd, McQuade MJ, Hanson BS. The effect of nicotine on the attachment of human fibroblasts to glass and human root surfaces in vitro. J Periodontol 1988;59:318-25.
  • 36 Tanur E, McQuade MJ, McPherson JC, Al-Hashimi IH, Rivera-Hidalgo F. Effects of nicotine on the strength of attachment of gingival fibroblasts to glass and non-diseased human root surfaces. J Periodontol 2000;71:717-22.
  • 37 Tipton DA, Dabbous MK. Effects of nicotine on proliferation and extracellular matrix production of human gingival fibroblasts in vitro. J Periodontol 1995;66:1056-64.
  • 38 Benowitz NL, Gourlay SG. Cardiovascular toxicity of nicotine: Implications for nicotine replacement therapy. J Am Coll Cardiol 1997;29:1422-31.
  • 39 Piao WH, Campagnolo D, Dayao C, Lukas RJ, Wu J, Shi FD. Nicotine and inflammatory neurological disorders. Acta Pharmacol Sin 2009;30:715-22.
  • 40 Cardinale A, Nastrucci C, Cesario A, Russo P. Nicotine: Specific role in angiogenesis, proliferation and apoptosis. Crit Rev Toxicol 2012;42:68-89.
  • 41 Konishi H, Wu J, Cooke JP. Chronic exposure to nicotine impairs cholinergic angiogenesis. Vasc Med 2010;15:47-54.
  • 42 Altarawneh S, Bencharit S, Mendoza L, Curran A, Barrow D, Barros S, et al. Clinical and histological findings of denture stomatitis as related to intraoral colonization patterns of Candida albicans, salivary flow, and dry mouth. J Prosthodont 2013;22:13-22.
  • 43 Sapp JP, Eversole LR, Wysocki GP. Epithelial disorders. Contemporary Oral and Maxillofacial Pathology. 2nd ed., Ch. 6. St Louis, Mo: Mosby; 2004. p. 190-1.
  • 44 Scully C, Ebrary I. Oral and Maxillofacial Medicine: The Basis of Diagnosis and Treatment. New York, Edinburgh: Churchill Livingstone; 2008.
  • 45 Sreebny LM, Vissink A, ebrary I. Dry Mouth: The Malevolent Symptom: A Clinical Guide. Ames, Iowa: Wiley-Blackwell; 2010. p. 245.
  • 46 Nouri-Shirazi M, Guinet E. Evidence for the immunosuppressive role of nicotine on human dendritic cell functions. Immunology 2003;109:365-73.
  • 47 Saeed R, Varma S, Peng T, Tracey KJ, Metz CN. The immunosuppressive effects of nicotine on endothelial cell activation and leukocyte trafficking in vivo. J Leukoc Biol 2004; p.37-8.
  • 48 Takahashi HK, Iwagaki H, Hamano R, Kanke T, Liu K, Sadamori H, et al. The immunosuppressive effects of nicotine during human mixed lymphocyte reaction. Eur J Pharmacol 2007;559:69-74.
  • 49 Pabst MJ, Pabst KM, Collier JA, Coleman TC, Lemons-Prince ML, Godat MS, et al. Inhibition of neutrophil and monocyte defensive functions by nicotine. J Periodontol 1995;66:1047-55.
  • 50 Mariggiò MA, Guida L, Laforgia A, Santacroce R, Curci E, Montemurro P, et al. Nicotine effects on polymorphonuclear cell apoptosis and lipopolysaccharide-induced monocyte functions. A possible role in periodontal disease? J Periodontal Res 2001;36:32-9.
  • 51 Malhotra R, Kapoor A, Grover V, Kaushal S. Nicotine and periodontal tissues. J Indian Soc Periodontol 2010;14:72-9.
  • 52 Thomé GR, Oliveira LS, Schetinger MR, Morsch VM, Spanevello RM, Fiorenza AM, et al. Nicotine alters the ectonucleotidases activities in lymphocytes:In vitro and in vivo studies. Biomed Pharmacother 2012;66:206-12.
  • 53 Theiss SM, Boden SD, Hair G, Titus L, Morone MA, Ugbo J. The effect of nicotine on gene expression during spine fusion. Spine (Phila Pa 1976) 2000;25:2588-94.
  • 54 Austin GW, Cuenin MF, Hokett SD, Peacock ME, Sutherland DE, Erbland JF, et al. Effect of nicotine on fibroblast beta 1 integrin expression and distribution in vitro. J Periodontol 2001;72:438-44.
  • 55 Zhou J, Olson BL, Windsor LJ. Nicotine increases the collagen-degrading ability of human gingival fibroblasts. J Periodontal Res 2007;42:228-35.
  • 56 Loo YK. Nicotine-induced osteonecrosis. A case report. Dent Update 2009;36:289-91.
  • 57 Bergström J. Smoking may impede gingival bleeding. J Evid Based Dent Pract 2005;5:29-30.
  • 58 Mavropoulos A, Aars H, Brodin P. Hyperaemic response to cigarette smoking in healthy gingiva. J Clin Periodontol 2003;30:214-21.
  • 59 Dietrich T, Bernimoulin JP, Glynn RJ. The effect of cigarette smoking on gingival bleeding. J Periodontol 2004;75:16-22.
  • 60 Morozumi T, Kubota T, Sato T, Okuda K, Yoshie H. Smoking cessation increases gingival blood flow and gingival crevicular fluid. J Clin Periodontol 2004;31:267-72.
  • 61 Katti N, Mohanty D, Asif K, Shatapathy N. Determination of efficacy of root planing in removal of nicotine from periodontally involved teeth of smokers. Chron Young Sci 2012;3:160.
  • 62 Chang YC, Tsai CH, Yang SH, Liu CM, Chou MY. Induction of cyclooxygenase-2 mRNA and protein expression in human gingival fibroblasts stimulated with nicotine. J Periodontal Res 2003;38:496-501.
  • 63 Johnson GK, Organ CC. Prostaglandin E2 and interleukin-1 concentrations in nicotine-exposed oral keratinocyte cultures. J Periodontal Res 1997;32:447-54.
  • 64 Wendell KJ, Stein SH. Regulation of cytokine production in human gingival fibroblasts following treatment with nicotine and lipopolysaccharide. J Periodontol 2001;72:1038-44.
  • 65 Payne JB, Johnson GK, Reinhardt RA, Dyer JK, Maze CA, Dunning DG. Nicotine effects on PGE2 and IL-1 beta release by LPS-treated human monocytes. J Periodontal Res 1996;31:99-104.
  • 66 Kim YS, Shin SI, Kang KL, Chung JH, Herr Y, Bae WJ, et al. Nicotine and lipopolysaccharide stimulate the production of MMPs and prostaglandin E2 by hypoxia-inducible factor-1α up-regulation in human periodontal ligament cells. J Periodontal Res 2012;47:719-28.
  • 67 Mortazavi H, Safi Y, Baharvand M, Jafari S, Anbari F, Rahmani S. Oral White Lesions: An Updated Clinical Diagnostic Decision Tree. Dent J (Basel) 2019,7:15. Doi: 10.3390/dj7010015.
  • 68 Naudi KB, Felix DH. Nicotine replacement lozenges: Abuse-related hyperkeratosis of the lateral border of the tongue. A case report. Br Dent J 2007;203:305-6.
  • 69 Chiang CH. Nicotine contributes to oral cancer by promotion of cell invasion through ASAP1 signaling pathway. Cancer Res 2013;73:6-10.
  • 70 Gemenetzidis E, Bose A, Riaz AM, Chaplin T, Young BD, Ali M, et al. FOXM1 upregulation is an early event in human squamous cell carcinoma and it is enhanced by nicotine during malignant transformation. PLoS One 2009;4:e48-9.
  • 71 Hamraz M, Salimi M, Esfahani M, Sedaghati B, Aslani HR, Bazarchi A. Nicotine effect on P-ERK, COX-2, PGE2 and VEGF expression in oral squamous cancer. J Biotechnol 2010;150:442-2.
  • 72 Viswanath K, Herbst RS, Land SR, Leischow SJ, Shields PG. And Writing Committee for the AACR Task Force on Tobacco and Cancer, Cancer Res 2010;70:3419-30. DOI: 10.1158/0008-5472.CAN-10-1087.
  • 73 Xu J, Huang H, Pan C, Zhang B, Liu X, Zhang L. Nicotine inhibits apoptosis induced by cisplatin in human oral cancer cells. Int J Oral Maxillofac Surg 2007;36:739-44.
  • 74 Bergström J. Cigarette smoking as risk factor in chronic periodontal disease. Community Dent Oral Epidemiol 1989;17:245-7.
  • 75 Bergström J, Eliasson S, Dock J. Exposure to tobacco smoking and periodontal health. J Clin Periodontol 2000;27:61-8.
  • 76 Preber H, Bergström J. The effect of non-surgical treatment on periodontal pockets in smokers and non-smokers. J Clin Periodontol 1986;13:319-23.
  • 77 Preber H, Bergström J. Effect of cigarette smoking on periodontal healing following surgical therapy. J Clin Periodontol 1990;17:324-8.
  • 78 Dolan TA, McGorray SP, Grinstead-Skigen CL, Mecklenburg R. Tobacco control activities in U.S. dental practices. J Am Dent Assoc 1997;128:1669-79.
  • 79 Henningfield JE. Nicotine medications for smoking cessation. N Engl J Med 1995;333:1196-203.
  • 80 Ferguson SG, Gitchell JG, Shiffman S, Sembower MA, Rohay JM, Allen J. Providing accurate safety information may increase a smoker’s willingness to use nicotine replacement therapy as part of a quit attempt. Addict Behav 2011;36:713-6.
  • 81 Shiffman S, Ferguson SG, Rohay J, Gitchell JG. Perceived safety and efficacy of nicotine replacement therapies among US smokers and ex-smokers: Relationship with use and compliance. Addiction 2008;103:1371-8.
  • 82 Vogt F, Hall S, Marteau TM. Understanding why smokers do not want to use nicotine dependence medications to stop smoking: Qualitative and quantitative studies. Nicotine Tob Res 2008;10:1405-13.
  • 83 Ismail AI, Bader JD, ADA Council on Scientific Affairs and Division of Science, Journal of the American Dental Association. Evidence-based dentistry in clinical practice. J Am Dent Assoc 2004;135:78-83.